N
WGS icon

Nuveen’s GeneDx Holdings WGS Stock Holding History

Nuveen’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.69M Sell
41,944
-681
-2% -$62.1K ﹤0.01% 2154
2025
Q4 		$5.54M Sell
42,625
-11,439
-21% -$1.57M ﹤0.01% 1867
2025
Q3 		$5.82M Buy
54,064
+11,598
+27% +$1.26M ﹤0.01% 1835
2025
Q2 		$3.92M Sell
42,466
-155,446
-79% -$12.2M ﹤0.01% 2000
2025
Q1 		$17.5M Buy
197,912
+547
+0.3% +$47.5K 0.01% 1202
2024
Q4 		$15.2M Buy
197,365
+3,084
+2% +$215K ﹤0.01% 1342
2024
Q3 		$8.25M Buy
194,281
+134,320
+224% +$4.54M ﹤0.01% 1729
2024
Q2 		$1.57M Buy
+59,961
New +$1.14M ﹤0.01% 2500
2023
Q2 		– Sell
-20,554
Closed -$248K – 3302
2023
Q1 		$248K Buy
20,554
+5,131
+33% +$68.4K ﹤0.01% 2950
2022
Q4 		$134K Sell
15,423
-5,633
-27% -$124K ﹤0.01% 3083
2022
Q3 		$610K Sell
21,056
-8,011
-28% -$367K ﹤0.01% 2910
2022
Q2 		$1.21M Buy
29,067
+26,553
+1,056% +$1.8M ﹤0.01% 2700
2022
Q1 		$233K Buy
+2,514
New +$279K ﹤0.01% 3163

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Nuveen's WGS Position: Q1 2026 in Review

Nuveen reduced its GeneDx Holdings (WGS) stake by 1.6% in Q1 2026, selling an estimated $62.1K and leaving 41,944 shares worth $2.69M. The position accounts for ﹤0.01% of the portfolio, ranked #2154.

Nuveen first reported a position in WGS in Q1 2022 and has held it in 13 quarters since. The position peaked at $17.5M in Q1 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Nuveen held 41,944 shares of GeneDx Holdings worth $2.69M as of Q1 2026.
  • Nuveen sold 681 GeneDx Holdings shares in Q1 2026, an estimated $62.1K.
  • GeneDx Holdings made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2154 holding.
  • Nuveen first reported a position in GeneDx Holdings in Q1 2022 and has held it in 13 quarters since.
  • Nuveen's GeneDx Holdings position peaked at $17.5M in Q1 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.